gemcitabine has been researched along with cucurbitacin b in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbassi, S; Doan, NB; Iwanski, GB; Koeffler, HP; Lin, P; Okamoto, R; Said, JW; Song, JH; Thoennissen, NH; Toh, M; Xie, WD; Yin, D | 1 |
| Bokemeyer, C; Castor, B; Doan, NB; En-Gal, S; Iwanski, GB; Koeffler, HP; Lee, DH; Said, JW; Thoennissen, NH; Toh, M; Vogt, M | 1 |
| Alvarez, R; Aribi, A; Chan, KT; Doan, NB; Gery, S; Ho, Q; Koeffler, HP; Lee, DH; Lee, K; Said, JW; Thoennissen, GB; Thoennissen, NH; Toh, M | 1 |
3 other study(ies) available for gemcitabine and cucurbitacin b
| Article | Year |
|---|---|
Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Female; Flow Cytometry; Gemcitabine; Giant Cells; Humans; Janus Kinases; Mice; Molecular Structure; Pancreatic Neoplasms; Signal Transduction; STAT Transcription Factors; Time Factors; Triterpenes; Xenograft Model Antitumor Assays | 2009 |
Cucurbitacin B, a novel in vivo potentiator of gemcitabine with low toxicity in the treatment of pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis Regulatory Proteins; Bone Marrow Cells; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Dose-Response Relationship, Drug; Drug Synergism; Enzyme Activation; Female; Gemcitabine; Humans; Mice; Mice, Nude; Pancreatic Neoplasms; Proto-Oncogene Proteins c-myc; Stem Cells; Triterpenes; Tumor Burden; Xenograft Model Antitumor Assays | 2010 |
The triterpenoid cucurbitacin B augments the antiproliferative activity of chemotherapy in human breast cancer.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; Bone Marrow Cells; Breast Neoplasms; Cell Line, Tumor; Cell Proliferation; Deoxycytidine; Docetaxel; Drug Synergism; Female; Gemcitabine; Humans; Mice; Taxoids; Triterpenes; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |